Adequacy of haemodialysis and associated factors among patients with end-stage kidney disease in Tanzania

被引:2
|
作者
Bakari, Abilah I. [1 ]
Yahaya, James J. [2 ]
Matobogolo, Boaz M. [1 ]
Abraham, Zephania S. [3 ]
Mpondo, Bonaventura [1 ]
机构
[1] Univ Dodoma, Sch Med & Dent, Dept Internal Med, Dodoma, Tanzania
[2] Soroti Univ, Sch Hlth Sci, Dept Pathol, POB 211, Soroti, Uganda
[3] Univ Dodoma, Sch Med & Dent, Dept Surg, Dodoma, Tanzania
来源
关键词
Adequacy; Chronic kidney disease; Clinical outcome; Factors associated; Haemodialysis; TWICE-WEEKLY HEMODIALYSIS; DIALYSIS INITIATION; MORTALITY; PREVALENCE; CARE;
D O I
10.1016/j.jtumed.2023.12.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Adequate haemodialysis helps maintain normal renal function by removing toxins and other waste products in patients with end-stage kidney disease. This study was aimed at determining the prevalence and predictors of adequacy of haemodialysis and outcomes in patients with end-stage kidney disease. Methods: This longitudinal analytical hospital-based study was conducted at two dialysis centres in Dodoma city, Tanzania, between February and July of 2020. Adequacy of haemodialysis was measured with single-pool (sp) Kt/V and urea reduction rate (URR) formulae. Binary logistic regression and multivariable analysis were used to assess the independent predictors of adequacy of haemodialysis. Results: The analysis included 100 patients with a mean age of 50.6 +/- 15.0 years. The prevalence of adequacy of haemodialysis according to URR and sp-Kt/V was 72 % and 75 %, respectively. Having <12 months since dialysis initiation (AOR = 7.3, 95 % CI = 0.11-0.90, p = 0.032), fewer than three dialysis sessions per week (AOR = 6.9, 95 % CI = 1.52-31.49, p = 0.013) and severe anaemia (AOR = 2.2, 95 % CI = 0.26-0.93, p = 0.033) were predictors of inadequate haemodialysis, according to the URR formula. Having fewer than three dialysis sessions per week was significantly associated with inadequate haemodialysis (AOR = 5.6, 95 % CI = 1.47-19.66, p = 0.011), according to the sp-Kt/V formula. The mortality rate was 11.2 %, and cardiovascular disease and uremic syndrome were responsible for most deaths. Conclusion: This study indicated a high percentage of adequacy of haemodialysis among patients with endstage kidney disease. Having fewer than three dialysis sessions per week, late initiation of dialysis after diagnosis of end-stage kidney disease and severe anaemia were predictors of inadequate haemodialysis among patients.
引用
收藏
页码:287 / 295
页数:9
相关论文
共 50 条
  • [41] Disparities in the Timing of Preoperative Hemodialysis Among Patients With End-Stage Kidney Disease
    Fielding-Singh, Vikram
    Vanneman, Matthew W.
    Morris, Arden M.
    Chertow, Glenn M.
    Lin, Eugene
    JAMA NETWORK OPEN, 2023, 6 (07)
  • [42] Psychosocial Factors in End-Stage Kidney Disease Patients at a Tertiary Hospital in Australia
    Bale, Charan
    Douglas, Alexandra
    Jegatheesan, Dev
    Pham, Linh
    Huynh, Sonny
    Mulay, Atul
    Ranganathan, Dwarakanathan
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2016, 2016
  • [43] Determinants of Medication Adherence among Jordanian Patients with End-Stage Kidney Disease
    Al-Sutari, Manal M.
    Abdelkader, Raghad H.
    Ababneh, Nour H.
    OPEN DENTISTRY JOURNAL, 2022, 16
  • [44] THE EFFECTS OF PHYSICAL EXERCISE IN CHRONIC END-STAGE KIDNEY FAILURE PATIENTS ON HAEMODIALYSIS
    Zagalaz Sanchez, Ma Luisa
    Pena Amaro, Pilar
    Martinez Vidal, Aurora
    Mateos Padorno, Covadonga
    Martinez Patino, Maria Jose
    JOURNAL OF HUMAN SPORT AND EXERCISE, 2010, 5 (01): : 101 - 113
  • [45] Is There Not Sufficient Evidence to Show That Haemodiafiltration Is Superior to Conventional Haemodialysis in Treating End-Stage Kidney Disease Patients?
    Canaud, Bernard
    Busink, Ellen
    Apel, Christian
    Bowry, Sudhir K.
    BLOOD PURIFICATION, 2018, 46 (01) : 7 - 11
  • [46] Population Pharmacokinetic Modelling of Apixaban in End-Stage Kidney Disease Patients with Atrial Fibrillation Receiving Haemodialysis
    Konecki, Celine
    Lipman, Mark L.
    Mavrakanas, Thomas A.
    Djerada, Zoubir
    CLINICAL PHARMACOKINETICS, 2025, 64 (02) : 307 - 321
  • [47] Comorbidity is not associated with dialysis modality choice in patients with end-stage kidney disease
    Bonenkamp, Anna A.
    Vonk, Sanne
    Abrahams, Alferso C.
    Vermeeren, Yolande M.
    van der Sluijs, Anita van Eck
    Hoekstra, Tiny
    van Ittersum, Frans J.
    van Jaarsveld, Brigit C.
    NEPHROLOGY, 2022, 27 (06) : 510 - 518
  • [48] Breath analysis in patients with end-stage renal disease: effect of haemodialysis
    Rolla, G.
    Bruno, M.
    Bommarito, L.
    Heffler, E.
    Ferrero, N.
    Petrarulo, M.
    Bagnis, C.
    Bugiani, M.
    Guida, G.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 (10) : 728 - 733
  • [49] Pharmacokinetics of Aliskiren in Patients with End-Stage Renal Disease Undergoing Haemodialysis
    Dmytro Khadzhynov
    Torsten Slowinski
    Ina Lieker
    Hans-Hellmut Neumayer
    Diego Albrecht
    Henk Johan Streefkerk
    Sam Rebello
    Harm Peters
    Clinical Pharmacokinetics, 2012, 51 : 661 - 669
  • [50] Early tooth loss in end-stage renal disease patients on haemodialysis
    Limeres, J.
    Garcez, J. F.
    Marinho, J. S.
    Loureiro, A.
    Diniz, M.
    Diz, P.
    ORAL DISEASES, 2016, 22 (06) : 530 - 535